Dr Baker's abstract, "Effect of testosterone therapy on quantitative breast lobular atrophy in transmasculine individuals" has been accepted for a Poster presentation at theApplications of Medical AI Workshop at Medical Image Computing and Computer Assisted Intervention (MICCAI) Meeting, Singapore.
Congratulations to Dr Baker. Her abstract, "Comparing the Immunohistochemistry Scoring of Breast Tumor Tissue Microarrays Using Definiens, InForm, and QuPath" has been accepted for Poster presentation at the CAP annual meeting 2022.
Dr. Heng will be speaking at a health disparity workshop organized by the NCI Center for Cancer Research and the Division of Cancer Epidemiology & Genetics.
She will present her group's multidisciplinary research on transgender breast cancer risk and treatment outcomes.
Dr. Heng was one of the speakers at the BIDMC Precision RNA Medicine Core Detection Workshop, "Tools for the discovery and validation of clinically important microRNA biomarkers” on Friday, April 29th at 9:00 AM – 10:30 AM ET.
The title of her talk was, "“Plasma miRNAs associated with cisplatin sensitivity in breast cancer.”
Dr. Heng joins the Program Commitee of the first workshop on Applications of Medical AI (AMAI), taking place as a Satellite Event of MICCAI 2022 on Sep 18 2022 in Singapore.
